FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $324,000 | -85.9% | 63,202 | -83.5% | 0.13% | -84.5% |
Q4 2017 | $2,301,000 | +38.1% | 382,838 | +6.6% | 0.81% | +28.1% |
Q2 2017 | $1,666,000 | +70.2% | 358,975 | +81.4% | 0.63% | +68.8% |
Q1 2017 | $979,000 | -55.4% | 197,838 | 0.0% | 0.38% | -62.1% |
Q4 2016 | $2,196,000 | – | 197,838 | – | 0.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,667,377 | $15,440,000 | 9.38% |
GREAT POINT PARTNERS LLC | 2,769,425 | $25,645,000 | 6.54% |
Opaleye Management Inc. | 630,000 | $5,834,000 | 3.05% |
Vivo Capital, LLC | 855,000 | $7,917,000 | 2.47% |
DAFNA Capital Management LLC | 278,067 | $2,575,000 | 1.79% |
RA Capital Management | 1,820,138 | $16,854,000 | 1.74% |
SENZAR ASSET MANAGEMENT, LLC | 523,397 | $4,846,656,000 | 1.25% |
Perceptive Advisors | 1,373,284 | $12,717,000 | 0.82% |
Monashee Investment Management LLC | 225,000 | $2,084,000 | 0.73% |
NEXTHERA CAPITAL LP | 125,000 | $1,158,000 | 0.71% |